The TGA has initiated a review of the labelling and packaging regulatory framework for prescription medicines, over the counter medicines and complementary medicines.

An external reference group has been established review consumer health risks related to medicines labels and packaging issues, including potential regulatory options for addressing these risks. In the initial meeting by the external group the following issues were reviewed: dispensing label space, look alike sound alike names and look alike packaging, umbrella branding, active ingredient prominence, small container labelling, label design, blister pack labelling, child resistant packaging and tamper evident packaging.
The TGA is currently exploring some of the suggestions from the group discussion and working with members of the reference group to develop a public consultation paper. The consultation paper is anticipated to be released in early 2012.